PRACTICE AREA

Food, Drugs and Medical Devices

The Food, Drugs and Medical Devices practice at PRK helps leading pharmaceutical, biotechnology, medical device, food, cosmetics and tobacco firms navigate the complex national and EU regulatory landscape. We advise clients on developing, manufacturing, marketing, promoting and distributing their products.

We also offer support in the area of pricing and reimbursement of drugs, biologics, medical devices and other regulated products. Besides our deep knowledge of the relevant legislation, we maintain a commercial focus and an understanding of our clients' priorities in their day-to-day business operations. We are able to do this in part thanks to the fact that many of our legal experts have themselves spent time working in the industry.
Více informací

Other Practice Areas

Bank- und Finanzrecht

Compliance

Geistiges Eigentum

Infrastruktur- und Energierecht

M&A

Insolvenz und Restrukturierung

Projekte und Investitionen

Publications by PRK on the regulation of the pharmaceutical industry
(2022)

Publications by PRK on the regulation of the pharmaceutical industry
(2021)

Read PRKs’ contribution to the Life Sciences 2021 Chambers Global
Practice Guides
(2021)

A strong legal team on your side

Monika Maskova

Partner


Monika Maskova
Jan Augustin

Rechtsanwalt


Jan Augustin
Martin Frolik

Rechtsanwalt


Martin Frolik
Show All

References

M&A / Lebens- und Arzneimittelrecht

Our longstanding client Teva Czech Industries s.r.o. and TAPI Czech Industries s.r.o., a leading global manufacturer of generic pharmaceuticals, in a major corporate reorganization involving the spin off part of the company focused on the development, production and sale of active pharmaceutical ingredients and plant extracts into a separate business entity.

M&A / Lebens- und Arzneimittelrecht

Sonoco Products Company on the Czech law aspects of the sale of Sonoco’s ThermoSafe business unit, one of the leading providers of temperature assurance technologies, to Arsenal Capital Partners, a leading private equity investment firm specializing in building market-leading industrial growth and healthcare companies.

We advised a major pharmaceutical company on the regulation of the pharmaceutical industry, including representing them before the State Institute for Drug Control in administrative procedures to determine maximum prices and dealing with issues related to pricing and reimbursement procedures.

We provided legal advice to a leading pharmaceutical company on the advertising of medicinal products, including helping them during proceedings related to an alleged breach of the industry code of ethics.

We advised a UK company providing clinical research services to the pharmaceutical and biotechnology industry, including reviewing their model contracts for clinical trials.